Menu Search Site

Samira Musah named 2018 Keystone Symposia Fellow

Fellows Program will foster high-level interaction with giants in the field and offer new insights on accelerating life science discovery

Samira Musah, Ph.D., Wyss Institute Postdoctoral Fellow

Wyss Institute Postdoctoral Fellow, Samira Musah, Ph.D., has been selected as a 2018 Keystone Symposia Fellow by the Keystone Symposia on Molecular and Cellular Biology. The Keystone Symposia Fellows Program is a highly unique, research-driven program that educates early-career scientists regarding the inner workings of the life sciences community and provides a venue for high-level interaction with established and leading scientists nationally and globally.

The Fellows Program provides context, understanding and insight regarding the development of high-powered research meetings, utilizing shadowing experiences with scientist organizers and key Keystone Symposia staff members. These experiences allow for learning how the research agenda is set, how to engage in high-level discourse on research topics and how to broaden perspectives in life science research.

Musah is most excited for the opportunity to develop the program agenda for future Keystone Symposia Conferences in the biomedical sciences and to shadow leading scientists during NIH study sessions where research grant proposals will be reviewed.

Keynote Symposia is a premier, nonprofit, life science research and education organization that has been accelerating life science discovery through high-quality research conferences since 1972.

At the Wyss Institute, Musah works with Founding Director Don Ingber and Core Faculty member George Church to apply stem cell biology and genome engineering technologies to develop patient-specific organs-on-chips.

Musah is the first author on a paper recently published in Nature Biomedical Engineering, which describes how she and her colleagues are engineering human stem cells to model the kidney’s filtration barrier on a chip. This advance could help model patient-specific kidney diseases and guide therapeutic discovery.

Close search results
Close menu